Q2 revenue exceeds $8.0B (5%+ above $7.65B guide), non-GAAP EPS >$2.80. Q3 FY2026 guided at $8.2B+. Management raises FY2026 outlook, explicitly reaffirms >20% CY2026 growth with upward bias. HBM equipment run-rate commentary implies >$2.5B annualized.
Q2 revenue $7.7-8.0B (meets/slightly beats consensus $7.69B), non-GAAP EPS $2.65-2.80. Q3 guided at $7.9-8.1B. Reaffirms >20% CY2026 growth without raising outlook. Gross margin sustains ~49%. Standard HBM/packaging commentary.
Q2 revenue <$7.4B, EPS <$2.50. Q3 guide below $7.5B. Management withdraws or significantly qualifies >20% growth. China headwind larger than $710M. Two or more top-5 customers signaling capex moderation. WFE cycle peak declared by management or implied by order patterns.
→ Stock at $431 is ABOVE thesis base target of $403 — current price requires a guidance raise (Scenario 1) to be justified. If holding, tighten stop-loss to $400 (original base level). A beat-and-maintain (Scenario 2) is already priced in.
→ If Q2 revenue >$8B AND Q3 guide >$8.2B: thesis re-rate needed. Bull target $476 becomes new base. Consider adding to position on confirmation.
→ If guidance misses (Scenario 3): expect -8-12% correction. Consider trimming 20% of position pre-earnings if conviction has declined. Re-entry target at $380-400 if base thesis still intact.
→ Pair trade consideration: if Castellano share-loss thesis is confirmed (Scenario 4), go long LRCX / short AMAT on competitive dynamics rotation within the WFE sector.
→ LRCX reports May 21 (one week after AMAT) — AMAT's results set the tone for the entire WFE sector. Watch LRCX stock reaction to AMAT's call as a cross-read on share dynamics.
AMAT Q2 FY2026 revenue exceeds $8.0B (vs $7.65B guidance midpoint), validating >20% CY2026 growth trajectory
If confirmed → thesis re-rate needed, bull target $476 becomes achievable. Consider adding on pullback.
AMAT Q2 FY2026 non-GAAP EPS exceeds consensus of $2.68, continuing the 4-quarter beat streak
If confirmed → supports margin expansion narrative. Watch magnitude — beat by >$0.10 is meaningful, <$0.05 is noise.
Q3 FY2026 guidance revenue midpoint exceeds $8.0B, implying sequential acceleration and H2 strength
If confirmed → base case revision upward needed, current $431 price justified. If Q3 guide <$7.8B → trim 20%.
Management explicitly reaffirms >20% CY2026 semiconductor equipment growth in prepared remarks or Q&A
If NOT reaffirmed (withdrawn or heavily qualified) → immediate bear signal, expect -8%+ selloff.
DRAM as percentage of Semi Systems revenue sustains at or above 33% in Q2 FY2026
If confirmed at 33%+ for 2nd consecutive quarter → strengthens secular content-per-wafer thesis. 3rd quarter at 33%+ = bull trigger confirmed.
Gross margin sustains at or above 49.0% in Q2 FY2026 (matching Q1 level)
If confirmed → favorable mix shift toward AI tools is durable. If drops below 48.5% → bear signal on mix deterioration.
China revenue declines to below 23% of total revenue in Q2 FY2026 (was ~25% in Q1)
If confirmed → export control + domestic mandate headwind accelerating. Watch for commentary on ICAPS tool restrictions.
Management provides a specific advanced packaging revenue figure for the first time (any dollar amount disclosed)
If disclosed at >$3B run-rate → packaging thesis crystallized, significant positive catalyst. Rare but high-impact.
AMAT stock closes above $445 within 2 trading days of earnings (May 16-19)
Requires strong beat + raise. At $431 pre-earnings, +3.3% post-earnings move implies Scenario 1. Below $420 implies Scenario 3+.
Management directly addresses or pushes back on the Castellano market share analysis during the earnings call
Unlikely — companies rarely address independent analyst critiques directly. If they do, the pushback quality matters more than the fact of response.
→ AMAT: Beat-and-raise Scenario 1 actualized. Bull target $476 within reach but stock already at ATH $448.45 — DO NOT chase. Add only on Samsung-labor / TSMC-stake-sale sector dips back to $410-420 zone. Original positioning ('If beat+raise: consider adding on pullback') still valid, but discipline on entry.
→ AMAT: Watch Morgan Stanley Equal-weight downgrade as the counter-signal — valuation + China exposure are real medium-term overhangs even at >30% CY26 growth. If stock holds >$460 on weak macro, position size becomes the risk.
→ MU / SKHynix: HBM equipment doubling validated and AMAT–SKHynix LT agreement confirms memory cycle anchor. Long memory bias intact. No add/trim trigger from this event alone.
→ KLAC: Standalone long signal — AMAT process control share concession is durable, not cyclical. Consider initiating or sizing up if price weakness emerges from sector sentiment.
→ AMKR: Advanced packaging +50% CY2026 forecast = bull signal. Watch AMKR's own next guidance for confirmation before adding.
→ LRCX: Drop pair-trade (long LRCX / short AMAT) — AMAT didn't admit broad share loss. LRCX remains standalone long via WFE upcycle.
→ Cross-sector: Equipment sector at >30% CY2026 growth + record AMAT margin = WFE cycle peak NOT here yet. Bear case (Scenario 6, p=0.05) decisively rejected for this earnings cycle.